论文部分内容阅读
胎儿宫内生长迟缓(IUGR)及小于胎龄儿(SGA),具有高围产儿死亡率及发病率。如何提高IUGR的诊断率,寻找有效的治疗方法,降低SGA的发生,曾是本院“七五”攻关的重点研究课题。过去沿用的葡萄糖加氨基酸静脉点滴疗法不够理想,为寻找一种经济有效的方法,本院于1990年1月开始试用一种完整均衡的医用口服营养剂——安素治疗IUGR,并进行了前瞻性临床研究。
Intrauterine growth retardation (IUGR) and small gestational age (SGA), with high perinatal mortality and morbidity. How to improve the diagnosis rate of IUGR, find effective treatment methods and reduce the occurrence of SGA have been the key research topics in the “Seventh Five-Year Plan” of our hospital. The past use of glucose plus amino acid intravenous drip therapy is not ideal, in order to find a cost-effective method, the hospital began in January 1990 trial of a complete and balanced medical oral nutritional agent - Ansu treatment IUGR, and made a preview Sexual clinical research.